Funded Tech Companies
Bayhill Therapeutics
Wondering who provided funding to Bayhill Therapeutics? Morgenthaler Ventures, U.S. Venture Partners and De Novo Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Bayhill Therapeutics
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1804 Embarcadero Rd. 201
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Company Background Information
Overview
Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/31/2008
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Operating Officer
Hideki Garren
VP - Finance
Kwang Lee
VP - Manufacturing
Robert King
VP - Regulatory Affairs
Joanne Quan
Company Investors
- Morgenthaler Ventures (James Broderick)
- U.S. Venture Partners (Philip Young)
- De Novo Ventures (Frederick Dotzler)
- Montreux Equity Partners
- Lilly Ventures
- Latterell Venture Partners
- Presidio Partners
- Lilly Ventures (David Thompson)
- De Novo Ventures (Fred Dotzler)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs